Axar.az
UP

Axar.Az Logo

US regulator approves Johnson&Johnson coronavirus vaccine

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The U.S. The Food and Drug Administration (FDA) approved the application of Janssen (owned by Johnson&Johnson) for an emergency use authorization of its vaccine against the novel coronavirus.

Axar.az reports that according to a statement released by the FDA under the US Department of Health and Human Services.

"Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older," according to the statement.

"The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States," said Acting FDA Commissioner Janet Woodcock, M.D.

Date
2021.02.28 / 17:32
Author
Axar.az
Comments
See also

WHO views world’s epidemiological situation as alarming

Global COVID-19 deaths surpass 3 mln

WHO: COVID cases, deaths rising at worrying rates

4 deaths after taking Russian Sputnik V vaccine

Coronavirus vaccine is prepared in spray form

Brazil finds new virus variant combining 18 mutations

WHO records over 517,000 new daily cases of COVID-19

WHO statement on "vaccination passport"

100M Americans received at least one vaccine dose

Yemen gets first COVID-19 vaccines

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla